Reda Bouabdallah
AuthID: R-00F-J6S
1
TITLE: Lenalidomide in combination with R-CHOP (R2-CHOP) as first-line treatment of patients with high tumour burden follicular lymphoma: a single-arm, open-label, phase 2 study
AUTHORS: Herve Tilly; Franck Morschhauser; Olivier Casasnovas; Thierry Jo Molina; Pierre Feugier; Steven Le Gouill; Corinne Haioun; Olivier Tournilhac; Reda Bouabdallah; Jean Gabarre; Thierry Lamy; Jose Cabecadas; Stephanie Becker; Fabrice Jardin; Nicolas Mounier; Gilles Salles;
PUBLISHED: 2018, SOURCE: LANCET HAEMATOLOGY, VOLUME: 5, ISSUE: 9
AUTHORS: Herve Tilly; Franck Morschhauser; Olivier Casasnovas; Thierry Jo Molina; Pierre Feugier; Steven Le Gouill; Corinne Haioun; Olivier Tournilhac; Reda Bouabdallah; Jean Gabarre; Thierry Lamy; Jose Cabecadas; Stephanie Becker; Fabrice Jardin; Nicolas Mounier; Gilles Salles;
PUBLISHED: 2018, SOURCE: LANCET HAEMATOLOGY, VOLUME: 5, ISSUE: 9
INDEXED IN: 
Scopus 
WOS
Scopus WOS2
TITLE: Statin use is safe and does not impact prognosis in patient with de novo follicular lymphoma treated with immunochemotherapy: An exploratory analysis of the PRIMA cohort study. Statin use in follicular lymphoma Full Text
AUTHORS: Emmanuel Bachy; Jane A Estell; Eric Van de Neste; Reda Bouabdallah; Joan Bargay; Alain Delmer; Benedicte Gelas Dore; Maria Gomes da Silva; Olivier Fitoussi; David Belada; Herve Maisonneuve; Tanin Intragumtornchai; Thierry Lamy; Peggy Dartigues; John Francis Seymour; Gilles Salles;
PUBLISHED: 2016, SOURCE: AMERICAN JOURNAL OF HEMATOLOGY, VOLUME: 91, ISSUE: 4
AUTHORS: Emmanuel Bachy; Jane A Estell; Eric Van de Neste; Reda Bouabdallah; Joan Bargay; Alain Delmer; Benedicte Gelas Dore; Maria Gomes da Silva; Olivier Fitoussi; David Belada; Herve Maisonneuve; Tanin Intragumtornchai; Thierry Lamy; Peggy Dartigues; John Francis Seymour; Gilles Salles;
PUBLISHED: 2016, SOURCE: AMERICAN JOURNAL OF HEMATOLOGY, VOLUME: 91, ISSUE: 4
3
TITLE: Rituximab maintenance for 2 years in patients with high tumour burden follicular lymphoma responding to rituximab plus chemotherapy (PRIMA): a phase 3, randomised controlled trial Full Text
AUTHORS: Gilles Salles; John Francis Seymour; Fritz Offner; Armando Lopez Guillermo; David Belada; Luc Xerri; Pierre Feugier; Reda Bouabdallah; John Vincent Catalano; Pauline Brice; Dolores Caballero; Corinne Haioun; Lars Moller Pedersen; Alain Delmer; David Simpson; Sirpa Leppa; Pierre Soubeyran; Anton Hagenbeek; Olivier Casasnovas; Tanin Intragumtornchai; ...More
PUBLISHED: 2011, SOURCE: LANCET, VOLUME: 377, ISSUE: 9759
AUTHORS: Gilles Salles; John Francis Seymour; Fritz Offner; Armando Lopez Guillermo; David Belada; Luc Xerri; Pierre Feugier; Reda Bouabdallah; John Vincent Catalano; Pauline Brice; Dolores Caballero; Corinne Haioun; Lars Moller Pedersen; Alain Delmer; David Simpson; Sirpa Leppa; Pierre Soubeyran; Anton Hagenbeek; Olivier Casasnovas; Tanin Intragumtornchai; ...More
PUBLISHED: 2011, SOURCE: LANCET, VOLUME: 377, ISSUE: 9759
4
TITLE: Updated Results of the PRIMA Study Confirms the Benefit of 2-Years Rituximab Maintenance In Follicular Lymphoma Patients Responding to Immunochemotherapy.
AUTHORS: Gilles Andre Salles; John Catalano; Pierre Feugier; Fritz C Offner; Reda Bouabdallah; Dolores Caballero; Pauline Brice; Lars Moller Pedersen; Corinne Haioun; David Belada; Alain Delmer; David Simpson; Herve Tilly; Sirpa Leppa; Pierre Soubeyran; Anton Hagenbeek; Olivier Casasnovas; Tanin Intragumtornchai; Christophe Ferme; Maria Gomes da Silva; ...More
PUBLISHED: 2010, SOURCE: 52nd Annual Meeting of the American-Society-of-Hematology (ASH) in BLOOD, VOLUME: 116, ISSUE: 21
AUTHORS: Gilles Andre Salles; John Catalano; Pierre Feugier; Fritz C Offner; Reda Bouabdallah; Dolores Caballero; Pauline Brice; Lars Moller Pedersen; Corinne Haioun; David Belada; Alain Delmer; David Simpson; Herve Tilly; Sirpa Leppa; Pierre Soubeyran; Anton Hagenbeek; Olivier Casasnovas; Tanin Intragumtornchai; Christophe Ferme; Maria Gomes da Silva; ...More
PUBLISHED: 2010, SOURCE: 52nd Annual Meeting of the American-Society-of-Hematology (ASH) in BLOOD, VOLUME: 116, ISSUE: 21
INDEXED IN: WOS
WOS